Xcout Intel
VeriSIM Life
VeriSIM Life provides an AI-driven drug discovery and development platform called BIOiSIM that uses mechanistic and quantitative methods to predict patient outcomes and de-risk clinical trials. The company serves pharmaceutical companies, biotechnology firms, and academic research institutions by generating actionable insights for drug repurposing, safety-toxicity profiles, and efficacy predictions.
Subscribe to see VeriSIM Life’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
VeriSIM Life at a glance
VeriSIM Life is a biotech company headquartered in United States. Xcout tracks 5 named people at VeriSIM Life, including Sanjay Pothen (Chief Financial Officer).
VeriSIM Life leadership
- Sanjay PothenChief Financial Officer
- Ed ParsleyChief Medical Officer
- Jo VarshneyFounder & Chief Executive Officer
- Dr. Vivek Gupta, Ph.D.Scientific Co-Founder
- Gordon MurtaughVice President, Corporate Development
VeriSIM Life competitors
A few of VeriSIM Life's closest competitors — see the full list of competitors and alternatives →
BioCorteX provides in-silico bridge trials for drug development to map how the microbiome affects a drug's efficacy across different populations. The company serves pharmaceutical science, regulatory, and commercial teams by determining for whom an asset works and why.
Founded in 2001 and headquartered in Oxford, UK, Physiomics Plc offers expert consulting services to pharmaceutical enterprises across the United Kingdom, the United States, and the European Union. The company's core specialization lies in outsourced quantitative pharmacology and computational biology. They deliver comprehensive modeling, simulation, and data analysis services primarily focused on oncology research and development, utilizing their proprietary Virtual Tumour predictive software. Additionally, Physiomics is engaged in developing innovative technologies for applications within the field of personalized medicine.
Bioneex provides an AI-powered biopharma matchmaking platform that connects early-stage drug development companies with strategic biopharma partners and venture capital investors. The platform facilitates licensing agreements, co-development partnerships, and investment opportunities for its users.
Formation Bio is a U.S.-based technology and drug-development company, formerly known as TrialSpark, that uses AI and software to help pharmaceutical companies develop medicines more efficiently. It serves biopharmaceutical partners by supporting clinical-trial operations and other parts of the drug-development process.
PhaseV uses causal machine learning and generative AI to optimize clinical trial designs and improve drug development processes.
Sai Life Sciences operates as a Contract Research, Development, and Manufacturing Organization (CRDMO) providing services from drug discovery to manufacturing. It serves pharmaceutical and biotech companies by offering capabilities in synthetic medicinal chemistry, biology, drug metabolism and pharmacokinetics, process development, and drug substance manufacturing.
Get VeriSIM Life's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on VeriSIM Life in Xcout Intel
- 5 named people with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access